Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dynamin 2 inhibitor for the treatment of centronuclear myopathies

Dynamin 2 inhibitor for the treatment of centronuclear myopathies

US Patent 10647986 · Granted May 12, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and method for the treatment of x-linked centronuclear myopathy2023
Compositions and method for the treatment of x-linked centronuclear myopathy2023
Dynamin 2 inhibitor for the treatment of centronuclear myopathies2022
Dynamin 2 inhibitor for the treatment of centronuclear myopathies2022
Dynamin 2 inhibitor for the treatment of centronuclear myopathies2022
Dynamin 2 inhibitor for the treatment of Duchenne's muscular dystrophy2020
Dynamin 2 inhibitor for the treatment of Duchenne's muscular dystrophy2020
Tyrosine-phosphatase-related protein2001